Proteomics International Partners with inVentiv Health Clinical
Proteomics International, a pretomics laboratory, has signed a collaborative agreement with inVentiv Health Clinical, provider of global research and bioanalytical services, with the intention of helping streamline the process from characterization to clinical trials.
Proteomics International's structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.